QCG
RGNX icon

Quadrant Capital Group’s Regenxbio RGNX Stock Holding History

Quadrant Capital Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.64K Buy
673
+19
+3% +$200 ﹤0.01% 2329
2025
Q4 		$9.42K Buy
654
+528
+419% +$6.58K ﹤0.01% 2220
2025
Q3 		$1.22K Buy
+126
New +$1.11K ﹤0.01% 2544
2025
Q2 		– Sell
-734
Closed -$5.25K – 2321
2025
Q1 		$5.25K Sell
734
-1,903
-72% -$14.2K ﹤0.01% 2345
2024
Q4 		$20.4K Buy
2,637
+825
+46% +$7.75K ﹤0.01% 1887
2024
Q3 		$19K Buy
1,812
+1,219
+206% +$14.9K ﹤0.01% 1914
2024
Q2 		$6.94K Buy
593
+545
+1,135% +$8.48K ﹤0.01% 2216
2024
Q1 		$1.01K Sell
48
-342
-88% -$6.09K ﹤0.01% 2586
2023
Q4 		$7K Buy
390
+274
+236% +$4.83K ﹤0.01% 2190
2023
Q3 		$1.91K Sell
116
-134
-54% -$2.43K ﹤0.01% 2404
2023
Q2 		$5K Buy
250
+233
+1,371% +$4.49K ﹤0.01% 2205
2023
Q1 		$322 Buy
+17
New +$376 ﹤0.01% 2644
2021
Q4 		– Sell
-8
Closed – – 2664
2021
Q3 		$0 Buy
+8
New +$288 ﹤0.01% 2622
2020
Q3 		– Sell
-24
Closed -$1K – 2282
2020
Q2 		$1K Buy
+24
New +$895 ﹤0.01% 2116
2019
Q2 		– Sell
-15
Closed – – 2387
2019
Q1 		$0 Buy
+15
New +$743 ﹤0.01% 2317

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quadrant Capital Group's RGNX Position: Q1 2026 in Review

Quadrant Capital Group increased its Regenxbio (RGNX) stake by 2.9% in Q1 2026, buying an estimated $200 and bringing the position to 673 shares worth $5.64K. The position accounts for ﹤0.01% of the portfolio, ranked #2329.

Quadrant Capital Group first reported a position in RGNX in Q1 2019 and has held it in 15 quarters since. The position peaked at $20.4K in Q4 2024. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • Quadrant Capital Group held 673 shares of Regenxbio worth $5.64K as of Q1 2026.
  • Quadrant Capital Group bought 19 Regenxbio shares in Q1 2026, an estimated $200.
  • Regenxbio made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2329 holding.
  • Quadrant Capital Group first reported a position in Regenxbio in Q1 2019 and has held it in 15 quarters since.
  • Quadrant Capital Group's Regenxbio position peaked at $20.4K in Q4 2024.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.